Table 5 Patient characteristics for the longitudinal analysis (n = 30). Values shown as mean ± SD or median (interquartile range)

Age (yr)

48.2 ± 16.0

Gender (% males)

63

Type diabetes (% T1/T2)

70/30

Duration of diabetes (yr)

17.3 ± 9.7

Height (cm)

167.7 ± 12.2

Weight (kg)

74.0 ± 16.1

BMI (kg/m²)

26.3 ± 4.4

mGFR (ml/min/1.73m²)

102.8 ± 27.9

MDRD (ml/min/1.73m²)

83.6 ± 27.8

CKD-EPI (ml/min/1.73m²)

88.3 ± 25.2

AER (μg/min)

17.8 ± (10.3, 52.5)

AER (% normo/micro/macro)

54/33/13

HbA _1c (%)

8.8 ± 1.3

HbA _1c (mmol/mol)

73

Fasting blood glucose (mmol/L)

11.4 ± 6.1

Systolic blood pressure (mmHg)

137.4 ± 17.7

Diastolic blood pressure (mmHg)

78.8 ± 9.5

Any blood pressure therapy (%)

77

ACE inhibitor therapy (%)

43

Lipid lowering therapy (%)

73

Fenofibrate

0

Retinopathy (%)

40

IHD (%)

13

CVD (%)

13

PVD (%)

10

History of macrovascular disease (%)

43